Navigation Links
Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan

SAN DIEGO, June 18, 2007 /PRNewswire-FirstCall/ -- Vical Incorporated today announced that the company's licensee, AnGes MG, Inc. reported positive results following interim analysis of data from the first 41 subjects to complete a Phase 3 trial of an angiogenesis product candidate using Vical's DNA delivery technology. Based on the findings that the primary efficacy endpoint in the trial had been achieved with statistical significance and that there were no major safety concerns related to treatment, an Independent Data Monitoring Committee (IDMC) recommended stopping the trial early to prevent potential ethical issues against the placebo group subjects. AnGes is ending the trial and preparing to file an application for Japanese marketing approval.

"The successful Phase 3 results from our Japanese licensee position the AnGes product candidate to be the first approved for human use based on our DNA delivery technology and provide proof of concept for DNA delivery in the treatment of disease," said Vijay B. Samant, President and Chief Executive Officer of Vical. "This novel approach has the potential to address an important, unserved medical need in a significant commercial market. We look forward to further updates from AnGes as they advance through the regulatory approval process."

The treatment uses Vical technology to deliver a gene encoding Hepatocyte Growth Factor (HGF), a human protein that causes angiogenesis (growth of blood vessels) in areas of ischemia (restricted blood flow). In the trial, 40 subjects with critical limb ischemia (advanced peripheral arterial disease) were evaluated for efficacy. The primary endpoints, improvement of rest pain ((VAS (Visual Analog Scale)) or ischemic ulcer size, at 12 weeks post dosing, showed 30.8% improvement in the placebo group and 70.4% improvement in the treatment group, a statistically significant difference (p=0.014).

The following English
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
4. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

Post Your Comments:
(Date:12/1/2009)...wswire-USNewswire/ -- ,, Overweight Children M..., A study from The Children,s Hospital at Montefi...verweight may be causing damage to their spines. R... adolescents between the ages of 12 and 20 who com...al over a four-year period. The results showed an ...
(Date:11/30/2009)... Nov. 30 Microban International, L...roduct protection, is pleased to announce their ex...rp., the largest U.S. manufacturer and distributor... is launching two new lines of ceramic tile with O...patent pending silver based technology, in order t...
(Date:11/30/2009)...v. 30 Covance Inc. (NYSE...the Piper Jaffray 21st Annual Health Care Conferen...). Investors may access a live webcast of the pre...ter and download any necessary software, please lo...rters in Princeton, New Jersey, is one of the worl...
Breaking Medicine Technology:Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2New role discovered for molecule important in development of the pancreas 51332 1New role discovered for molecule important in development of the pancreas 51332 2New role discovered for molecule important in development of the pancreas 51332 3A matter of density not quantity 9206 1A matter of density not quantity 9206 2Millipore Sues W L Gore 26 Associates for Patent Infringement 51331 1Millipore Sues W L Gore 26 Associates for Patent Infringement 51331 2Millipore Sues W L Gore 26 Associates for Patent Infringement 51331 3
... Results Presented at Endocrine Society,s 90th Ann...f., June 16 ,Bionovo Inc. (Nasdaq: BNVI ) today a...y elements important in developing drugs for breas...esented at the Endocrine Society,s,90th Annual Mee...essential,for the differentiation of the estrogeni...
...AN DIEGO, June 16 Victory Pharma, Inc., a special...ted areas of medicine, today,announced the recent ...r,MGX006 antiemetic pivotal clinical program., "D...rmulation selection,and end-of-phase 2 discussions...igns provides confidence that MGX006 will move rap...
Other Medicine Technology:Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs 2Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs 3
(Date:12/1/2009)..., SMITHFIELD, R.I., Dec. 1 In t...umptions are hazardous and can result in injury --...ulation, a handful of persistent bad assumptions a...s of occupational Hearing Conservation Programs ...hite paper from Howard Leight, " Bad Assumption...
(Date:12/1/2009)... ,, NEW YORK, Dec. 1 Ovid, part...he development and delivery of customizable electr...fic and academic markets, will be showcasing recen...-to-market cross-platform search solution, and the... on the American Psychological Association,s (APA,...
(Date:12/1/2009)...c. 1 The following is b... Development: ,, Chairman Kerry, Ranking Member...onored to be nominated by President Obama to serve...International Development, and I appreciate his co...y of State Clinton has expressed the conviction th...
(Date:12/1/2009)...afety Authority Encourages Older Persons and Healt...umer Tips Based Upon Authority Data ,, HARRIS...y percent of all vaccine preventable deaths occur ...ing homes, according to highlighted studies in the...mber Patient Safety Advisory . ,, According to...
(Date:12/1/2009)...2009. Performing surgical operations without leav...e a reality. This is demonstrated by the recent su...Transluminal Endoscopy Surgery), an innovative sur...he body,s natural orifices. The results are all ad... hospital stay and faster recovery. Currently, thi...
Breaking Medicine News(10 mins):Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3
...ortality and survival rates equal for both procedu...- Minimally-invasive laparoscopic surgery and open..., according to researchers who reviewed findings f... in colorectal cancer patients and cause metastase...
...pokesperson for Education Campaign on Behalf of CS...se Inhibitor (Human) Augmentation ... 17 Melissa Biggs, a fashion,designer and actress...r alpha-1 antitrypsin (AAT) deficiency,after her o...
... 16 There,s more to a healthy mouth than,flashing...ca,s oral care,habits - and what it means for our ...Health America & Philips Sonicare at:, http://medi... and,photos for free and unrestricted use at http...
...mpaign to Emphasize the Importance of Oral and Ove...ntal insurer United,Concordia Dental is celebratin...al Health America and the British Dental Health Fo...t time,making it the largest independent internati...
...hronic disease sufferers gain benefit from calcitr...thDay News) -- Taking activated vitamin D may cut ...re chronic kidney disease by about one quarter, a ...had their overall risk of death lowered by 26 perc...
...Save Vital Services for Frail Seniors and People W...nds of,homecare workers across the state are outra...to hours of service, wages and benefits,which woul...ors and people with disabilities from Schwarzenegg...
Other Medicine News:Health News:Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: